1. PKDS009 study group;Rinne;Drugs,1998
2. Pharmacodynamic and pharmacokinetic features of cabergoline;Fariello;Drugs,1998
3. Cabergoline in Parkinsons’s disease: long-term follow-up;Lera;Neurology,1993
4. The effect of food on cabergoline pharmacokinetics and tolerability in healthy volunteers;Persiani;Biopharm. Drug Dispos,1996
5. M.S. Benedetti, E. Pianezzola, S. Persiani, R. Grimaldi, J.A. Obeso, Evaluation of the linearity of cabergoline pharmacokinitics in parkinsonian patients, in: 10th International symposium on Parkinson’s disease, Tokyo, 27–30 October 1991.